Skip to main content

Table 1 Baseline characteristics of PLWHA at the start of CPT on BMH before February 2012

From: Retrospective evaluation of cotrimoxazole use as preventive therapy in people living with HIV/AIDS in Boru Meda Hospital

Conditions

Variables

Number (%)

HIV infection clinical stage

I

37 (14.92)

II

66 (26.61)

III

123 (49.60)

IV

22 (8.87)

Co morbid illness

TB

29 (11.69)

Fungal infection

31 (12.75)

PCP

2 (0.8)

Others

18 (7.26)

Laboratory results

CD4 count <350 cell/mm3

221 (89.11)

Hemoglobin <7 g/dl

4 (1.61)

Platelet count < 50,000 cells/dl

4 (1.61)

Neutrophil count < 750 cells/dl

3 (1.2)

 

ALT > 115 IU/L (for males) >90 IU/L (for females)

3 (1.2)

  1. ALT- alanine transaminase, IU- international unit.